PDS Biotechnology Corp. (PDSB)
PDS Biotechnology Market Cap : 64.75M for May 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Altimmune, Inc. | 558.14M |
| INmune Bio, Inc. | 36.95M |
| Humacyte, Inc. | 224.24M |
| ACADIA Pharmaceuticals, Inc. | 3.646B |
| Alnylam Pharmaceuticals, Inc. | 40.05B |
Market Cap Related Metrics
| Price to Book Value | 16.63 |
| Price | 1.16 |
| Earnings Yield | -57.81% |